Chiesi Group ("Chiesi"), the international research focused biopharmaceutical company and a certified B Corp, and Bespak, the specialist inhalation CDMO focused on pulmonary and nasal drug delivery, ...
As health systems seek to balance innovation with the need to address sustainability, increasing attention is being paid to ...
WOODBURY, Minn.--(BUSINESS WIRE)--Kindeva Drug Delivery, a global leader in contract drug delivery development and manufacturing services and technology, and H&T Presspart (a division of the Heitkamp ...
Chiesi Group proudly shares its contribution to the thought-provoking series "The Climate and Us", presented by the Global Climate and Health Alliance and produced for them by BBC StoryWorks. The ...
Agreement builds on existing Chiesi-Bespak collaboration, reinforcing a trusted relationship as Chiesi works to evolve a portfolio of extrafine formulation Carbon Minimal Inhalers1, ensuring patients ...
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260311319953/en/ Chiesi Group ("Chiesi"), the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results